Impact of Treatment with Renin-Angiotensin System Inhibitors on Clinical Outcomes in Hypertensive Patients Hospitalized with COVID-19.

Martin Negreira-CaamañoJesus Piqueras-FloresJorge Martínez-DelRioPatricia Nieto-Sandoval-Martin-DeLaSierraDaniel Aguila-GordoCristina Mateo-GomezDaniel Salas-BravoMarta Rodriguez-MartinezMartín Negreira-Caamaño

Published in: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension (2020)

The use of ACEi or ARB was associated with less incidence of all-cause death during hospitalisation among hypertensive patients admitted with COVID-19 respiratory infection.

Keyphrases

hypertensive patients
blood pressure
coronavirus disease
sars cov
risk factors
replacement therapy